☆ 4.7 Editorial Material

The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)

Related references

Note: Only part of the references are listed.

Review Nutrition & Dietetics

A Critical Review of Multimodal Interventions for Cachexia

Clare McKeaveney et al.

Summary: The review highlighted the lack of standardized treatments for cachexia or severe wasting and the need for multimodal interventions in addressing these conditions. While the studies showed some improvements in body composition, nutrition, biomarkers, and functionality in treatment groups, caution is required due to the heterogenous nature of interventions and small sample sizes. Overall, there is support for the role of multimodal interventions in treating severe wasting, but further randomized controlled trials with a powered sample size and sufficient interaction period are necessary to determine their effectiveness.

ADVANCES IN NUTRITION (2021)

Add to Collection

Article Geriatrics & Gerontology

Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment

Liang-Kung Chen et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)

Add to Collection

Review Geriatrics & Gerontology

Nutrition interventions to treat low muscle mass in cancer

Carla M. Prado et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)

Add to Collection

Article Oncology

Management of Cancer Cachexia: ASCO Guideline

Eric J. Roeland et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Geriatrics & Gerontology

Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium

Shalender Bhasin et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2020)

Add to Collection

Article Oncology

A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia

Satoshi Hamauchi et al.

CANCER (2019)

Add to Collection

Editorial Material Geriatrics & Gerontology

Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019

Stephan von Haehling et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)

Add to Collection

Article Oncology

Anamorelin (ONO-7643) for the Treatment of Patients With Non-Small Cell Lung Cancer and Cachexia: Results From a Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Japanese Patients (ONO-7643-04)

Nobuyuki Katakami et al.

CANCER (2018)

Add to Collection

Article Oncology

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

D. Currow et al.

ANNALS OF ONCOLOGY (2017)

Add to Collection

Article Oncology

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

Jennifer S. Temel et al.

LANCET ONCOLOGY (2016)

Add to Collection

Article Oncology

Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial

Koichi Takayama et al.

SUPPORTIVE CARE IN CANCER (2016)

Add to Collection

Editorial Material Geriatrics & Gerontology

Request for regulatory guidance for cancer cachexia intervention trials

K. C. H. Fearon et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)

Add to Collection

Editorial Material Geriatrics & Gerontology

Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin

Stefan D. Anker et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)

Add to Collection

Review Geriatrics & Gerontology

Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management

Hidetaka Wakabayashi et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.